Amneal Pharmaceuticals, Inc. (AMRX) › Shareholders' EquityAmneal Pharmaceuticals, Inc. (AMRX) — Shareholders' EquityAnnual figures by period end, from SEC filings.2017-10-04: $02017-12-31: $02018-12-31: $504.75M2019-12-31: $232.01M2020-12-31: $303.27M2021-12-31: $360.34M2022-12-31: $298.42M2023-12-31: $19.78M2024-12-31: -$109.27M2025-12-31: -$70.79M-$70.79M2017-10-04Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31-$70.79M—2026-02-27Balance as of period end2024-12-31-$109.27M-652.4%2026-02-27Balance as of period end2023-12-31$19.78M-93.4%2025-02-28Balance as of period end2022-12-31$298.42M-17.2%2024-03-14Balance as of period end2021-12-31$360.34M+18.8%2023-03-03Balance as of period end2020-12-31$303.27M+30.7%2022-03-01Balance as of period end2019-12-31$232.01M-54.0%2021-03-01Balance as of period end2018-12-31$504.75M—2020-03-02Balance as of period end2017-12-31$0—2018-03-09Balance as of period end2017-10-04$0—2018-03-09Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)